Form 8-K - Current report:
SEC Accession No. 0001104659-24-128428
Filing Date
2024-12-13
Accepted
2024-12-13 16:14:40
Documents
13
Period of Report
2024-12-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431083d1_8k.htm   iXBRL 8-K 27008
  Complete submission text file 0001104659-24-128428.txt   200826

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eyen-20241212.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20241212_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20241212_pre.xml EX-101.PRE 22359
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2431083d1_8k_htm.xml XML 3666
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 241548501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)